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1. Introduction
The liver is the vertebrates’ largest internal organ. It weighs nearly 1.5 kg, is dark red in col‐
or, and is situated in the upper right quadrant of the abdominal cavity. Among the functions
that it performs are the following: the metabolism of lipids and carbohydrates, and the syn‐
thesis of proteins, coagulation factors, and biliary salts. Eighty percent of the hepatic paren‐
chyma is made up of hepatocytes, which are the cells mainly responsible for maintaining
every function that the liver in its entirety requires to sustain the body’s normal physiologi‐
cal functions in general. In addition to hepatocytes, the liver possesses other cells, such as
the so-called Kupffer cells (hepatic macrophages), Ito cells, endothelial cells. The hepato‐
cytes are disposed in the liver in groups denominated lobules, which have a central orifice
comprised of the bile duct and by means of which the biliary salts are excreted. The anatom‐
ical loss of the structure of the hepatic lobule is considered a symptom of severe damage to
the liver; it can be accompanied by partial or total loss of some physiological function, as in
the case of alcohol-related hepatic cirrhosis. [23].
2. Hepatic regeneration
Liver regeneration is a fundamental response of the liver on encountering tissue damage.
The complex interaction of factors that determine this response involves a stimulus (experi‐
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mentally, a hepatectomy), gene expression, and the interaction of other factors that modu‐
late the response. This proliferation depends on the hepatocytes, epithelial bile cells, Kupffer
cells, and Ito cells. [24].
The mechanisms of hepatic growth have been studied in detail in experimental models. In the
latter, regeneration is induced whether by tissue resection (partial hepatectomy) or by death of
the hepatocytes (toxic damage). The principles that govern the growth of this organ in these
systems also apply to clinical situations, such as, for example, fulminating liver failure, acute
and chronic hepatitis, partial hepatectomy for treating liver cancer, or even in liver transplant
donors. Evidence that there is a humoral growth factor of the hepatocyte has been observed in
animal models and in patients with liver disease from the 1980s. [1, 13, 34, 10].
3. Ethanol
On being ingested, alcohol (also called ethanol) produces a series of biochemical reactions
that lead to the affectation of numerous organs involving economy, having as the endpoint
the development of hepatic diseases such as alcoholic hepatitis and cirrhosis. Despite that
much is known about the physiopathological mechanisms that trigger ethanol within the or‐
ganism, it has been observed that a sole mechanism of damage cannot fully explain all of the
adverse effects that ethanol produces in the organism or in one organ in particular. [37, 30].
A factor that is referred as playing a central role in the many adverse effects that ethanol
exerts on the organism and that has been the focus of attention of many researchers is the
excessive generation of molecules called free radicals, which can produce a condition known
as oxidative stress, which triggers diverse alterations in the cell’s biochemical processes that
can finally activate the mechanism of programmed cell death, also known as apoptosis. [28,
26, 17, 19, 25].
Of particular importance for the objective of this chapter is the focus on a particular class of
free radicals that are oxygen derivatives, because these are the main chemical entities that
are produced within the organism and that affect it in general.
4. Ethanol metabolism
Ethanol is absorbed rapidly in the gastrointestinal tract; the surface of greatest adsorption is
the first portion of the small intestine with 70%; 20% is absorbed in the stomach, and the re‐
mainder, in the colon. Diverse factors can cause the increase in absorption speed, such as
gastric emptying, ingestion without food, ethanol dilution (maximum absorption occurs at a
20% concentration), and carbonation. Under optimal conditions, 80-90% of the ingested dose
is completely absorbed within 60 minutes. Similarly, there are factors that can delay ethanol
absorption (from 2-6 hours), including high concentrations of the latter, the presence of
food, the co-existence of gastrointestinal diseases, the administration of drugs, and individu‐
al variations [14, 37].
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Once ethanol is absorbed, it is distributed to all of the tissues, being concentrated in greatest
proportion in brain, blood, eye, and cerebrospinal fluid, crossing the feto-placentary and
hematocephalic barrier [44]. Gender difference is a factor that modifies the distributed etha‐
nol volume; this is due to its hydrosolubility and to that it is not distributed in body fats,
which explains why in females this parameter is found diminished compared with males.
Ethanol is eliminated mainly (> 90%) by the liver through the enzymatic oxidation path‐
way;  5-10% is  excreted  without  changes  by  the  kidneys,  lungs,  and  in  sweat  [14,  30].
The  liver  is  the  primary  site  of  ethanol  metabolism through the  following  three  differ‐
ent  enzymatic  systems:  Alcohol  dehydrogenases  (ADH);  Microsomal  ethanol  oxidation
system (MEOS);  Catalase  system.
5. Liver regeneration and ethanol
Ethanol is a well known hepatotoxic xenobiotic because hepatotoxicity has been well docu‐
mented in humans as well as in animals. Although aspects concerning the pathogenesis of
liver damage have been widely studied, it is known that liver regeneration restores the func‐
tional hepatic mass after hepatic damage caused by toxins. Suppression of the regenerating
capacity of the liver by ethanol is the major factor of liver damage. [45]. Although the effects
of acute or chronic administration of ethanol on the proliferative capacity of the liver to re‐
generate itself has been studied, the precise mechanism by which ethanol affects hepatocel‐
lular function and the regenerative process are poorly explained. [31, 29, 38].
Liver regeneration induced by partial hepatectomy in rats represents an ideal model of con‐
trolled hepatocellular growth. This surgical procedure has been sufficiently employed to
study the factors than can be implicated in the growth of the liver. Endogenous signals have
been described to control hepatic regeneration. The first marker of DNA synthesis in partial‐
ly hepatectomized rats (70%) occurring normally 24-28 hours postsurgery comprises an
enormous action of growth factors and cytokines affecting expression of the gene of the hep‐
atocytes, associated with initiation of the cell cycle. [2]. It has indicated that the hepatocytes
enter into a state denominated “priming” to thus begin replication and response to growth
factors, that is, which range from the quiescent to the G 1 phase of the cell cycle. The pro‐
gression of hepatic cells requires the activation of cyclin-dependent kinases that are regulat‐
ed by cyclins and cyclin-dependent kinase inhibitors. [39]. It has also been demonstrated
that a dose of ethanol importantly diminishes the specific activity of two enzymes related
with the metabolism of DNA synthesis, which are thymidine kinase and thymidylate syn‐
thetase. [47, 11, 32].
6. Free radicals
Free radicals are the result of the organism’s own physiological processes, such as the me‐
tabolism of food, respiration, exercise, or even those generated by environmental factors,
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such as contamination, tobacco, or by drugs, chemical additives, etc. Free radicals (FR) are
atoms or groups of atoms that in their atomic structure present one or more unpaired elec‐
trons (odd in number) in the outer orbit. This spatial configuration generates in the molecule
distinct physical and chemical properties such as heightened reactivity and diminished life‐
time, respectively. [5, 27].
This instability confers on these physical avidity for the uptake of an electron of any other
molecule in its ambit (stable molecules), causing the affected structure to remain unstable
with the purpose of reaching its electrochemical stability. Once the free radical has achieved
trapping the electron that it requires for pairing with its free electron, the stable molecule
that cedes the latter to it in turn becomes a free radical, due to its remaining with an un‐
paired electron, this initiating a true chain reaction that destroys our cells. [4, 7].
In aerobic cells, there are diverse pathways that lead to the production of Oxygen-derived
free radicals (OFR). The main sources are enzymes associated with the metabolism of arachi‐
donic acid, such as cycloxygenase, lipoxygenase, and cytochrome P-450. The presence and
ubiquity of enzymes (superoxide dismutase, catalase, and peroxidase) that eliminate secon‐
dary products in a univalent pathway in aerobic cells suggest that the superoxide anions
and hydrogen peroxide are important secondary products of oxidative metabolism. [40, 7].
Reactive oxygen species (ROS) can damage macromolecules such as DNA, carbohydrates,
and proteins. These cytotoxic oxygen species can be classified as two types:
1. the free radicals, such as the superoxide radical (O2) and the hydroxyl radical (˙OH),
and
2. non-radical oxygen species, such as hydrogen peroxide (H2O2), the oxygen singlette
(O1), which is a very toxic species, peroxynitrite (ONOO), and Hypochlorous acid
(HOCL).
The instable radicals attack cell components, causing damage to the lipids, proteins, and the
DNA, which can trigger a chain of events that result in cellular damage. [7, 21]. These reduc‐
tive processes are accelerated by the presence of trace metals such as iron (Fe) and copper
(Cu) and of specific enzymes such as monoxygenases and certain oxidases. [7, 21]
7. Oxidative stress
In 1954, an Argentine researcher, Rebeca Gerschman, suggested for the first time that FR
were toxic agents and generators of disease. [12].
Due to the atomic instability of FR, the latter collide with a biomolecule and subtract an elec‐
tron, oxidating it, losing in this manner its specific function in the cell. If lipids are involved
(polyunsaturated fatty acids), the structures rich in these are damaged, such as the cell
membranes and the lipoproteins. In the former, the permeability is altered, leading to edema
and cell death, and in the latter, to oxygenation of the Low-density lipoproteins (LDL) and
genesis of the atheromatous plaque. The characteristics of lipid oxygenation by FR involve a
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chain reaction in which the fatty acid, on being oxygenated, becomes a fatty acid radical
with the capacity of oxidizing another, neighboring molecule. This process is known as lipid
peroxidation and it generates numerous subproducts, many of these, such as Malondialde‐
hyde (MDA), whose determination in tissues, plasma, or urine is one of the methods for
evaluating oxidative stress. In the case of proteins, these preferentially oxidize the amino
acids (phenylalanine, tyrosine, triptophan, histidine, and methionine), and consequently
form peptide chain overlapping, protein fragmentation, and the formation of carbonyl
groups, and these impede the normal development of their functions (ionic membrane
transporters, receptors, and cellular messengers), enzymes that regulate the cell’s metabo‐
lism, etc.). [7, 33].
8. Liver regeneration, ethanol, and free radicals
While ROS and FR are generated during ethanol metabolism, causing oxidative stress and
lipoperoxidation in the liver, they can also form a significant pathway of damage to the re‐
generative process of the hepatocyte. In this process, ethanol-induced FR and the generation
of ROS involve the mitochondria, the microsomal cytochrome P450 2E1, the iron (FE) ion,
and less frequently, peroxisomes, cytosolic xanthines, and aldehyde oxidases, to regulate
cellular proliferation, acting as direct or indirect factors. [37, 2].
In general, ROS-derived FR intervene in the persistent bombardment of molecules by reac‐
tive oxygen radicals, thus maintaining redox homeostasis, in such a manner that during liv‐
er regeneration, these can modify the metabolic response necessary for carrying out cellular
mitosis in the hepatocyte. While FR are generated and utilized by the cells as neutrophils,
monocytes, macrophages, eosinophils, and fibroblasts for eliminating foreign organisms or
toxic substances, the increase of FR due to exposure to ethanol leads to cellular deterioration
that in turn produces hepatic alterations, with an unfavorable influence on cell proliferative
action. [25].
9. Antioxidants
Halliwell defines an antioxidant as all substances that on being found present at low concen‐
trations with respect to those of an oxidizable substrate (biomolecule), delays or prevents
the oxidation of this substrate. The antioxidant, on colliding with FR, is ceded to an electron,
in turn oxidizing itself and transforming itself into a non-toxic, weak FR and, in some cases
such as with vitamin E, it can regenerate itself into its primitive state due to the action of
other antioxidants. Not all antioxidants act in this way: the so-called enzymatic antioxidants
catalyze or accelerate chemical reactions that utilize substrates that in turn react with FR. Of
the numerous classifications of antioxidants, it is recommended to adopt that which divides
these into the following: exogenes or antioxidants that enter through the alimentary chain,
and endogenes that are synthesized by the cell. Each antioxidant possesses an affinity for a
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determined FR or for several. Vitamin E, beta-carotene, and lycopene act within the liposol‐
uble medium of the cell and their absorption and transport are found to be very much
linked with that of the lipids. Vitamin E is considered the most important protector of lipid
molecules. [27].
Life in the presence of molecular oxygen requires the possession of a multiple battery of de‐
fenses against the diverse oxygen FR, which on the one hand tend to impede their formation
and on the other, neutralize them once they are formed. These defenses exert an effect at five
levels [7, 21, 33]:
9.1. First level
This consists of editing univalent oxygen reduction through enzymatic systems capable of
effecting consecutive tetravalent reduction without releasing the partially reduced interme‐
diaries; this is achieved with great effectiveness by the cytochrome-oxidase system of the
mitochondrial respiratory chain, which is responsible for more than 90% of oxygen reduc‐
tion in the human organism.
9.2. Second level
This is constituted of enzymes specialized in the uptake of the superoxide anion radical (O 2
‒). These are Superoxide dismutase (SOD), the methaloenzyme that catalyzes the dismuta‐
tion of the superoxide anion radical to provide molecular oxygen and hydrogen peroxide,
with such great effectiveness that it approaches the theoretical limit of diffusion. In the cells
of the eukaryotic organisms, there are two of these: one is cytoplasmatic, and the other is
mitochondrial. SOD was described by Fridovich in 1975.
9.3. Third level
This is conferred by a group of specialized enzymes on neutralizing hydrogen peroxide.
Among these is catalase, which is found in the peroxisomes and which catalyzes the dismu‐
tation reaction.
Also in mammals, glutathione peroxidase (a cytoplasmic enzyme that contains selenium) is
the most important.
9.4. Fourth level
Here the hydroxyl radical produced in the Haber-Weiss cycle can neutralized by vitamin E
or alpha-tocopherol, which is an effective antioxidant and that due to its hydrophobicity is
found in biological membranes in which its protection is particularly important. In addition,
vitamin C or ascorbic acid is a reducer agent or electron donor and reacts rapidly with the
OH‒ radical and with the superoxide anion.
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9.5. Fifth level
Once the molecular damage is produced, there is a fifth level of defense that consists of re‐
pair. It has been demonstrated that FR were capable of causing breaks in the DNA chain and
even of inducing mutagenesis, but there are enzymatic repair mechanisms that permit rees‐
tablishment of genetic information.
10. Antioxidants and their role in hepatoprotection
The term antioxidant was originally utilized to refer specifically to a chemical product that
prevented the consumption of oxygen [6]; thus, antioxidants are defined as molecules whose
function is to delay or prevent the oxygenation of other molecules. The importance of anti‐
oxidants lies in their mission to end oxidation reactions that are found in the process and to
impede their generating new oxidation reactions on acting in a type of sacrifice on oxidating
themselves. There are endogenous and exogenous antioxidants in nature. Some of the best-
known exogenous antioxidant substances are the following: β‐carotene (pro‐vitamin A); reti‐
nol (vitamin (A); ascorbic acid (vitamin C); α‐tocopherol (vitamin E); oligoelements such as
selenium; amino acids such as glycine, and flavonoids such as silymarin, among other organ‐
ic compounds [46, 36].
Historically, it is known that the first investigations on the role that antioxidants play in Bi‐
ology were centered on their intervention in preventing the oxidation of unsaturated fats,
which is the main cause of rancidity in food. However, it was the identification of vitamins
A, C, and E as antioxidant substances that revolutionized the study area of antioxidants and
that led to elucidating the importance of these substances in the defense system of live or‐
ganisms. [36].
Due to their solubilizing nature, antioxidant compounds have been divided into hydrophil‐
ics (phenolic compounds and vitamin C) and lipophilics (carotenoids and vitamin E). The
antioxidant capacity of phenolic compounds is due principally to their redox properties,
which allow them to act as reducing agents, hydrogen and electron donors, and individual
oxygen inhibitors, while vitamin C’s antioxidant action is due to its possessing two free elec‐
trons that can be taken up by Free radicals (FR), as well as by other Reactive oxygen species
(ROS), which lack an electron in their molecular structure. Carotenoids are deactivators of
electronically excited sensitizing molecules, which are involved in the generation of radicals
and individual oxygen, and the antioxidant activity of vitamin A is characterized by hydro‐
gen donation, avoiding chain reactions. [7, 21, 33].
The antioxidant defense system is composed of a group of substances that, on being present
at low concentrations with respect to the oxidizable substrate, delay or significantly prevent
oxygenation of the latter. Given that FR such as ROS are inevitably produced constantly
during metabolic processes, in general it may be considered as an oxidizable substrate to
nearly all organic or inorganic molecules that are found in living cells, such as proteins, lip‐
ids, carbohydrates, and DNA molecules. Antioxidants impede other molecules from binding
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to oxygen on reacting or interacting more rapidly with FR and ROS than with the remainder
of molecules that are present in the microenvironment in which they are found (plasma
membrane, cytosol, the nucleus, or Extracellular fluid [ECF]). Antioxidant action is one of
the sacrifices of its own molecular integrity in order to avoid alterations in the remainder of
vitally functioning or more important molecules. In the case of the exogenic antioxidants, re‐
placement through consumption in the diet is of highest importance, because these act as
suicide molecules on encountering FR, as previously mentioned. [7, 21, 33].
This is the reason that, for several years, diverse researchers have been carrying out experi‐
mental studies that demonstrate the importance of the role of antioxidants in protection
and/or hepatic regeneration in animals. Thus, in this chapter, the principal antioxidants will
be described that play an important role in the regeneration of hepatic cells and in the pre‐
vention of damage deriving from alcohol.
11. Flavonoids
Flavonoids are compounds that make up part of the polyphenols and are also considered
essentials nutrients. Their basic chemical structure consists of two benzene rings bound by
means of a three-atom heterocyclic carbon chain. Oxidation of the structure gives rise to sev‐
eral families of flavonoids (flavons, flavonols, flavanons, anthocyanins, flavanols, and isofla‐
vons), and the chemical modifications that each family can undergo give rise to >5,000
compounds identified by their particular properties. [16].
Flavonoid digestion, absorption, and metabolism have common pathways with small differ‐
ences, such as, for example, unconjugated/non-conjugated flavonoids can be absorbed at the
stomach level, while conjugated flavonoids are digested and absorbed at the intestinal level
by extracellular enzymes on the enterocyte brush border. After absorption, flavonoids are
conjugated by methylation, sukfonation, ands glucoronidation reactions due to their biologi‐
cal activity, such as facilitating their excretion by biliary or urinary route. The conjugation
type the site where this occurs determine that metabolite’s biological action, together with
the protein binding for its circulation and interaction with cellular membranes and lipopro‐
teins. Flavonoid metabolites (conjugated or not) penetrate the tissues in which they possess
some function (mainly antioxidant), or are metabolized. [27].
On the other hand, the flavonoids possess implications in health; in recent years, the proper‐
ties of these compounds have been studied in relation to diverse pathologies. In diabetes,
these compounds present regulation of glycemia through diverse mechanisms that include
the inhibition of some enzymes such as α-glucosidase, glucose 6 phosphatase, and phos‐
phorylated glycogen. The flavonoids possess other characteristics such as the trapping of
molecules of glioxal and methyl-glioxal molecules, which propitiate the formation of ad‐
vanced final products of glycosylation that are found to be directly related with micro- and
macrovascular complications. They also regulate the rise or fall of transporter proteins; the
structure of some flavonoids appears to have important participation with regard to the
studied benefits. [16].
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More research is needed because great majority of the former has been conducted in ani‐
mals, to determine effects and dosage. Flavonoids in the menopause result in controversial
effects due to the population type studied, that is, Asiatic, absorption, metabolism, the bind‐
ing of isoflavones to estrogen receptors, etc.; however, they appear to possess a beneficial
effect in terms of the prevention of certain types of cancer and osteoporosis. [16].
The flavonoids absorb Ultraviolet light (UV) from the sun and possess direct and indirect
antioxidant effects (through the induction of cytoprotector proteins). Topical application (on
the human skin) of the polyphenolic fraction of green tea protects against immunosuppres‐
sion and inhibits the erythema and the formation of pyrimidine dimers in DNA caused by
UV. On representing one of the most important lifestyle factors, alimentation can important‐
ly affect the incidence and initiation of cardiovascular or neurodegenerative diseases. The
cardioprotector effect of flavonoids is based on reducing oxidation and blood concentrations
of the binding of cholesterol to Low-density lipoproteins (LDL); flavonoids reduce endothe‐
lial dysfunction and blood pressure and increase the HDL-bound cholesterol concentration.
Flavonoids possess a neuroprotector effect because they protect the neurons from oxidative
stress by means of induction of antioxidant defenses, modulation of signaling cascades, mi‐
tochondrial interactions, apoptotic processes, or by synthesis/degradation of the β-amyloid
peptide. The potential effect of flavonoids as neuroprotectors is due to three main factors:
they prevent neurodegeneration; inhibit neuroinflammation, and reduce the diminution of
age-related cognitive functions. [16].
In cancer, the flavonoids have been classified as chemopreventive, as blockers as well as in‐
hibitors, given their functions in carcinogenesis, in which they modulate transduction sig‐
naling in cellular proliferation and angiogenesis, modulate enzymes for the metabolic
activation of procarcinogens and the detoxification of carcinogens, and modulate enzymes
in the biosynthesis of anti-oxidant-pro-oxidant estrogen activity estrogen (promoting oxida‐
tive homeostasis, rendering its antioxidative capacity as a contribution to antineoplastic as
well as preventive as well as therapeutic activity due to inhibiting the activation of mitogen‐
ic kinases and transduction factors, while pro-oxidative activity increases the cell damage
that promotes detention of the cell cycle and apoptosis). In obesity, the flavonoids have been
identified as reducer factors of fat mass and as inhibitors of fat mass deposition and catabo‐
lic activity. [16].
The procyanidins and proanthocyanidins have demonstrated, in human population, to di‐
minish visceral fatty mass (depending on the dose) with an associated increase of adiponec‐
tin. This diminution is linked with the malabsorption of carbohydrates and lipids due to
enzyme inhibition. It has been observed that the procyanidins increase β-oxidation and in‐
hibit the expression of genes that promote the synthesis of fatty acids. Epigallocatechin gal‐
late can increase energy expenditure and lipid oxidation in humans; it is thought that this is
possible because of the increase of thermogenesis and the inhibition of the activity of the li‐
pase, as well as, according to studies in vitro, the inhibition of lipogenesis and apoptosis of
the adipocytes. Catechins that alter the deposition of adipose tissue related with diminution
of the respiratory co-efficient and greater oxygen consumption, and thermogenesis induced
by the sympathetic nervous system. Phytoestrogens can improve obesity and its alterations
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on diminishing insulin resistance, thus lipogenesis, as well as inhibition of the mechanisms
for cell differentiation and proliferation. The study of flavonoids and their effects on the pre‐
vention and treatment of obesity is a widespread, yet incomplete research field. [16].
The metabolism of phytoestrogens and their maximum concentration in serum presents
great variability, depending on genetic differences and estrogen exposure in early life
stages. [16].
12. Silimarina (silybum marianum)
Silymarin is a compound of natural origin extracted from the Silybum marianum plant, popu‐
larly known as St. Mary’s thistle, whose active ingredients are flavonoids such as silybin, si‐
lydianin, and silycristin. This compound has attracted attention because of its possessing
antifibrogenic properties, which have permitted it to be studied for its very promising ac‐
tions in experimental hepatic damage. In general, it possesses functions such as its antioxi‐
dant one, and it can diminish hepatic damage because of its cytoprotection as well as due to
its inhibition of Kupffer cell function. [41].
Silymarin, derived from the milk thistle plant named Silybum marianum, has been used since
time past as a natural remedy for combating liver diseases. Silymarin and its active constitu‐
ents (silybinin, silycristin, and silydianine, among others), have been classified as uptakers
of free radicals and inhibitors of lipoperoxidation; some studies also suggest that that they
increase the synthesis of hepatocytes, diminish the activity of tumor promoters, stabilize
mastocyte cells, and act as iron chelates. [8].
Silybum marianum belongs to the Aster family (Asteraceae or Compositae), which includes
daisies and thistles. The milk thistle is distributed widely throughout Europe, was the first
plant that appeared in North America to the European colonizers, and is at present estab‐
lished in the South of the U.S., California, and South America. [22].
The name milk thistle is derived from the characteristics of its thorny leaves with white
veins, which, according to the legend, were carried by the Virgin Mary. Its name Cardo lecho‐
so derives from the same tradition. The mature plant has large flowers, of a brilliant purple
color, and abundant thorns of significant appearance. The milk thistle grows in places where
exposure to the sun is abundant. [15].
Extracts of the milk thistle have been used as medical remedies from ancestral Greece, when
Dioscorides, a Greek herbalist, wrote that the seeds of the milk thistle could cure the bite of a
poisonous snake. Pliny noted that the mixture of the juice of the plant and its honey were
excellent for bile tract disorders. [9]. In 1596, Gerard mentioned Silybum marianum as a major
remedy against melancholy or black bile. The milk thistle was sold for treating liver diseas‐
es. In the 1960s, observed that milk thistle was an excellent remedy for cleaning obstructions
of the liver and spleen, notwithstanding that infusions of the fresh roots and seeds were ef‐
fective for counteracting jaundice.
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The main active agent of the milk thistle is silymarin, a mixture of flavonolignans, silydia‐
nine, silycristin, and silybinin, the latter the most biologically active extract; the flavonoids
appear to be activated as trappers of free radicals and as plasmatic membrane stabilizers.
Concentrations of silymarin are localized in the fruit of the plant, as well as in the seeds and
leaves, from which silymarin is extracted with 95%-proof ethanol, achieving a brilliant yel‐
low liquid. The term flavonoid is derived from flavus, which denotes yellow. [20, 16].
The standardized extract of silymarin contains 70% silymarin. Pharmacokinetic studies have
shown that there is rapid absorption of silybinin into the bloodstream after an oral dose.
Steady-state plasma concentrations are reached after 2 hours and the elimination half-life is
6 hours. [Lorenz et al., 1984, 3]. From 3-8% of an oral dose is excreted in the urine and from
20-40% is recovered in the bile as glucuronide and sulfate. [42].
Silybinin works as an antioxidant, reacting rapidly with oxygen free radicals as demonstrat‐
ed in vitro with hydroxyl anions and hypochlorous acid. Reported activities include the in‐
hibition of hepatocyte lipoperoxidation, the microsomal membrane in rats, and protection
against genomic damage through the suppression of hydrogen peroxide, superoxide anions,
and lipoxygenase. It is thought that silybinin also increases the synthesis of the proteins of
the hepatocyte through stimulation of the activity of the ribosomal RNA (rRNA) polymer‐
ase. In addition, silybinin diminishes hepatic and mitochondrial oxidation induced by an
iron overcharge and acts as an iron chelate. [16].
13. Antioxidant and hepatoprotector action
Silymarin is an active principle that possesses hepatoprotector and regenerative action; its
mechanism of action derives from its capacity to counterarrest the action of FR, which are
formed due to the action of toxins that damage the cell membranes (lipid peroxidation),
competitive inhibition through external cell membrane modification of hepatocytes; it forms
a complex that impedes the entrance of toxins into the interior of liver cells and, on the other
hand, metabolically stimulates hepatic cells, in addition to activating RNA biosythesis of the
ribosomes, stimulating protein formation. In a study published by [41], the authors ob‐
served that silymarin’s protector effect on hepatic cells in rats when they employed this as a
comparison factor on measuring liver weight/animal weight % (hepatomegaly), their values
always being less that those of other groups administered with other possibly antioxidant
substances; no significant difference was observed between the silymarin group and the sily‐
marin-alcohol group, thus demonstrating the protection of silymarin. On the other hand, sily‐
marin diminishes Kupffer cell activity and the production of glutathione, also inhibiting its
oxidation. Participation has also been shown in the increase of protein synthesis in the hepa‐
tocyte on stimulating polymerase I RNA activity. Silymarin reduces collagen accumulation
by 30% in biliary fibrosis induced in rat. An assay in humans reported a slight increase in
the survival of persons with cirrhotic alcoholism compared with untreated controls [2].
Silymarin is a flavonoid derived from the Silybum marianum plant that has been employed
for some 2,000 years for the treatment of liver diseases. At present, its use as an alternative
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drug has extended throughout Europe and the U.S. Silymarin acts as a hepatoprotector due
to its antioxidant effect, which has been observed to inhibit liver damage due to the releas‐
ing of the substances of free radicals, such as ethanol, acetaminophen, and Carbon tetra‐
chloride (CCL4), in addition to increasing the activity of SOD and glutathione. As a uptaker
of free radicals, silymarin can inhibit the lipid peroxidation cascade in the cell membranes.
The hepatoprotector effect of this flavonoid also can be explained by an anti-inflammatory
effect, in which it has been observed that silymarin acts on the functions of the Kupffer cells.
Inhibition also has been reported in the activation of the Nuclear kappa-Beta [NK-B) tran‐
scription factor. [2, 16, 7, 21, 33].
14. Silymarin and Exercise
During physical activity, oxygen consumption increases, which produces oxidative stress
that leads to the generation of free radicals, which are highly toxic for the cell, because these
interact with organic molecules susceptible to being oxidized, such as unsaturated fatty
acids, which causes lipoperoxidation. To avoid this damage by FR, there are the following
antioxidant systems: Superoxide-dismutase (SOD), and Catalase (CAT), in addition to other
protector substances such as vitamins A, C, and E and the flavonoids, which trap free radi‐
cals. (unpublished data)
In experiments conducted by our research group on groups of rats that were submitted to
daily aerobic exercise in a physical-activity cage for 20 minutes during 4 weeks (5 days/
week) and on another group of rats submitted to physical activity plus administration of
silymarin (200 mg/kg of weight) prior to exercise, with daily quantification of physical per‐
formance and at the at the end of the experiment, quantification of DNA in serum and of
SOD and CAT activity in liver. We found that in the group with physical activity, MDA in‐
creased 134% (in serum) and 123% (in liver) vs. control rats. In the group with exercise plus
silymarin, MDA returned to normality (in serum and in liver). Catalase activity increases
during exercise (118%) and with exercise plus silymarin (137%). SOD activity exhibited no
modifications in any treatment. Finally, we found an increase of physical activity in the
group administered silymarin (27%) in comparison with the group in which no silymarin was
administered. (unpublished data)
A protector effect was found of silymarin during exercise, because it diminishes MDA levels
in serum as well as in liver, which translates into diminution of the production of free radi‐
cals, causing as a consequence less cellular damage, which in turn leads to an increase in
physical performance.
15. Conclusions
The process of the induction of oxidative stress generated in the liver due to the presence of
ethanol implies the conjugation of various factors. The role that these factors play in the de‐
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velopment of oxidative stress depends in part on whether acute or chronic intoxication is in‐
volved. The factors that contribute to the development of oxidative stress imply
disequilibrium among pro- and antioxidant factors. It can occur that oxidative stress devel‐
ops if the xenobiotic increases the pro-oxidant factors (the generation of Oxygen-generated
free radicals [OFR]) or decreases intracellular antioxidant factors. In whichever of the two
cases, the general result is important damage to the hepatocyte that can lead to general dam‐
age to the DNA that, in turn, can comprise a determining factor in the induction of the apop‐
totic system (programmed cell death) of the cell, thus accelerating its death and destruction.
The study of the factors that determine the increase in the generation of OFR in the liver,
originating due to acute or chronic intoxication with a xenobiotic, is of great importance be‐
cause it will allow diminishing the damage that these reactive species produce within the
hepatocyte. On the other hand, despite that at present much is known concerning the physi‐
opathological mechanisms of ethanol ingestion-related liver damage and the role that the
production of oxygen-generated free radicals plays in these processes, the exact extent of
this damage, as well as how to prevent it, remains unknown with precision. There is evi‐
dence obtained from laboratory models that the ingestion of natural antioxidants, such as
vitamins A, C, and E, oligoelements (selenium), amino acids (glycine), and principally flavo‐
noids, such as silymarin, can in the future be a potential treatment for all persons who
present hepatic alterations. However, beyond the remedy, the cooperation of the patient is
required to regulate his/her ethanol consumption; as long as this does not take place, taking
antioxidant vitamins can be considered within the regular therapy of a patient with alcohol‐
ism, taking care above all that this supplement does not reach toxic concentrations, in partic‐
ular in the case of the vitamin that possess the tendency to accumulate in the liver.
The use of novel experimental procedures that determine the degree of damage caused by
xenobiotics, and in particular by free radicals, is of great importance in the management of
diseases caused by this type of substance, especially if they damage the liver, because this
organ comprises a vital part of our organism on having in its charge the metabolic support
of the latter.
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